OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SCL.PSX55

Shield Corp Ltd

Personal ProductsVerified

Shield Corp Ltd's capital structure is highly leveraged, with a debt-to-equity ratio of 1.89, indicating significant reliance on debt financing. The company's liquidity position is medium risk, with a current ratio of 0.71, suggesting limited short-term liquidity to cover immediate obligations. Despite a negative net income of PKR -198.25 million, the company generated positive operating cash flow of PKR 232.20 million, which partially offsets the free cash flow deficit of PKR -213.88 million. Profitability metrics are weak, with a return on equity of -31.16% and a return on assets of -7.26%, both significantly below industry norms. The company's operating margin is negative at -25.45%, and its net margin is -32.05%, indicating poor cost control and pricing power. These metrics suggest the company is underperforming relative to its peers in the Personal Products industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. Growth trajectory is negative, with a net income decline of 32.05% and an operating income decline of 25.45% in the latest period. The company's capital expenditures of PKR -209.30 million suggest ongoing investment in operations, but the negative free cash flow indicates that these investments are not yet generating sufficient returns. The company faces moderate liquidity risk due to its current ratio of 0.71 and a negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution sources identified in the latest filings. However, the company's negative net income and high debt levels may necessitate future equity or debt financing, which could introduce dilution risk. Recent filings and transcripts indicate ongoing operational challenges, including cost overruns and supply chain disruptions. The company has not disclosed any major strategic initiatives or product launches in the latest reports, which may impact its ability to reverse its current financial trajectory.

30-day price · SCL.PSX-184.00 (-19.7%)
Low$750.00High$1125.00Close$750.00As of14 May, 00:00 UTC
Profile
CompanyShield Corp Ltd
TickerSCL.PSX
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Shield Corp Ltd operates in the Personal Products industry, manufacturing and selling personal care products to consumers, primarily generating revenue through product sales.

Classification. Shield Corp Ltd is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a classification confidence of 0.92.

Shield Corp Ltd's capital structure is highly leveraged, with a debt-to-equity ratio of 1.89, indicating significant reliance on debt financing. The company's liquidity position is medium risk, with a current ratio of 0.71, suggesting limited short-term liquidity to cover immediate obligations. Despite a negative net income of PKR -198.25 million, the company generated positive operating cash flow of PKR 232.20 million, which partially offsets the free cash flow deficit of PKR -213.88 million. Profitability metrics are weak, with a return on equity of -31.16% and a return on assets of -7.26%, both significantly below industry norms. The company's operating margin is negative at -25.45%, and its net margin is -32.05%, indicating poor cost control and pricing power. These metrics suggest the company is underperforming relative to its peers in the Personal Products industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. Growth trajectory is negative, with a net income decline of 32.05% and an operating income decline of 25.45% in the latest period. The company's capital expenditures of PKR -209.30 million suggest ongoing investment in operations, but the negative free cash flow indicates that these investments are not yet generating sufficient returns. The company faces moderate liquidity risk due to its current ratio of 0.71 and a negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution sources identified in the latest filings. However, the company's negative net income and high debt levels may necessitate future equity or debt financing, which could introduce dilution risk. Recent filings and transcripts indicate ongoing operational challenges, including cost overruns and supply chain disruptions. The company has not disclosed any major strategic initiatives or product launches in the latest reports, which may impact its ability to reverse its current financial trajectory.
Key takeaways
  • Shield Corp Ltd is highly leveraged with a debt-to-equity ratio of 1.89, indicating significant financial risk.
  • The company's profitability metrics are poor, with a return on equity of -31.16% and a return on assets of -7.26%.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional or sector-specific risks.
  • Growth is negative, with a net income decline of 32.05% and an operating income decline of 25.45%.
  • The company faces moderate liquidity risk and may require additional financing to sustain operations.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$619.1M
Gross profit$35.6M
Operating income-$157.3M
Net income-$198.2M
R&D
SG&A
D&A
SBC
Operating cash flow$232.2M
CapEx-$209.3M
Free cash flow-$213.9M
Total assets$2.73B
Total liabilities$2.10B
Total equity$636.2M
Cash & equivalents
Long-term debt$1.21B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$2.15B$280.5M$155.1M$148.3M
FY-3$2.66B$111.7M$17.8M-$592.5M
FY-2$4.36B$430.8M$145.0M$22.3M
FY-1$3.87B-$66.9M-$362.7M-$452.2M
FY0$2.97B-$113.8M-$12.7M-$9.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.51B$594.0M
FY-3$2.40B$604.0M
FY-2$2.93B$748.9M
FY-1$2.73B$636.2M
FY0$2.24B$1.13B
PeriodOCFCapExFCFSBC
FY-4$227.7M-$79.1M$148.3M
FY-3-$86.2M-$675.5M-$592.5M
FY-2$150.9M-$223.5M$22.3M
FY-1$232.2M-$209.3M-$452.2M
FY0-$324.8M-$120.3M-$9.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$619.1M-$157.3M-$198.2M-$213.9M
FQ-6$719.9M$2.1M-$57.9M-$49.3M
FQ-5$876.1M$31.4M$259.9M$274.8M
FQ-4$762.2M$29.8M-$13.3M-$31.3M
FQ-3$607.6M-$177.1M-$201.4M-$203.5M
FQ-2$717.7M-$6.3M-$36.2M-$49.2M
FQ-1$587.5M$21.7M-$4.1M-$25.2k
FQ0$697.7M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.73B$636.2M
FQ-6$2.73B$938.3M
FQ-5$2.56B$1.20B
FQ-4$2.50B$1.18B
FQ-3$2.24B$1.13B
FQ-2$2.06B$1.13B
FQ-1$2.10B$1.13B
FQ0$1.16B
PeriodOCFCapExFCFSBC
FQ-7$232.2M-$209.3M-$213.9M
FQ-6-$229.3M-$22.4M-$49.3M
FQ-5-$342.7M-$39.0M$274.8M
FQ-4-$319.3M-$87.6M-$31.3M
FQ-3-$324.8M-$120.3M-$203.5M
FQ-2$42.4M-$37.4M-$49.2M
FQ-1$88.9M-$58.7M-$25.2k
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$636.2M
Net cash-$1.21B
Current ratio0.7
Debt/Equity1.9
ROA-7.3%
ROE-31.2%
Cash conversion-1.2%
CapEx/Revenue-33.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
MetricSCL.PSXActivity
Op margin-25.4%6.0% medp25 0.5% · p75 12.6%bottom quartile
Net margin-32.0%5.2% medp25 0.5% · p75 10.9%bottom quartile
Gross margin5.8%43.2% medp25 26.0% · p75 61.0%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-33.8%-3.0% medp25 -5.5% · p75 -1.3%bottom quartile
Debt / equity189.0%13.3% medp25 2.5% · p75 55.2%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:22 UTC#a6666e73
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 08:27 UTCJob: 391a3033